INTOX Pvt. Ltd.

A Contract Research Organization (CRO), INTOX performs a wide range of studies, including Toxicological, Mutagenicity, Ecotoxicological and Chemical, for Pharmaceutical, Crop Protection / Agrochemical, Biotechnological, Chemical and Medical devices industries which wish to obtain National and International registration of their new products, with the respective Governmental regulatory authorities.

Today, INTOX is one of the most trusted names in safety assessment, with its GLP compliance been endorsed by regulators from India and Europe.

GVK Biosciences Pvt. Ltd.

GVK BIO, Asia’s leading Contract Research Organization (CRO). In an ever-evolving market, we enable clients to address their drug development challenges with an effective combination of science, innovation and people. Lower costs, boosted efficiencies and an infusion of fresh ideas make us the chosen partner for many global Pharmaceutical and Biotechnology companies.

TCG Lifesciences Ltd.

TCG Lifesciences Limited (formerly "Chembiotek Research International") is a leading contract research services company in the area of early drug discovery and development. We started our operations in the year 2001 in India, currently we have our presence in United States, Europe, Japan and Australia.

We have a strong talent pool of 800+ qualified and trained scientists, drawn from the best national and international institutes and industry.

Biocon Limited

Biocon is an emerging global biopharmaceutical enterprise focused on delivering affordable innovation. It is committed to reduce therapy costs of chronic diseases like diabetes, cancer and autoimmune diseases by leveraging India's cost advantage to deliver affordable healthcare solutions to patients, partners and healthcare systems across the globe.

Asian Clinical Trials Pvt. Ltd.

Asian Clinical Trials (ACT) is a full-fledged CRO providing complete solutions for global pharmaceutical, biotechnology and medical device companies in clinical research. ACT aims to maximize customer value by providing high quality, cost effective, professionalized services.

Accutest Research Laboratories Pvt. Ltd.

Accutest Research Laboratories (I) Pvt. Ltd., the leading independent and internationally accredited Contract Research Organization (CRO) in India, was founded back in 1998 by Dr. Satish Sawant and Dr. Santosh Joshi and is headquartered in Navi Mumbai. It primarily focused in conducting Bioavailability and Bioequivalence studies for the generic pharmaceutical industry. For over a decade Accutest’s success in Bioavailability/Bioequivalence services has earned it a strong reputation in the field both in domestic and international markets.

Novella Clinical Inc.

Novella Clinical is a full service clinical research organization dedicated to clients in the oncology, medical device and biopharmaceutical industries. Novella has served as a trusted outsourcing partner for Sponsors for fifteen years. Novella’s transparent, collaborative and proactive approach to clinical trial management allows our clients to move products to market faster and into the hands of people who need them.


PSI is a leading full-service global Contract Research Organization whose key strength is predictable patient enrollment across multiple therapeutic areas.

PSI is known in the industry as a CRO focused on on-time project delivery. This is achieved through investing substantial effort and MD resources into performing quality feasibility assessments that provide an accurate predictor of study timelines.

PSI’s global reach allows us to run clinical trials across multiple continents and countries around the world.

Medpace, Inc.

A global leader in research-based drug and device development, Medpace builds strong strategic partnerships with select Sponsors to advance the most efficient and cost-effective path to drug and device approval. As a therapeutically-focused Clinical Research Organization (CRO), we view ourselves as stewards of your drug and device, leveraging our extensive medical and regulatory expertise to deliver additional input, strategy, and efficiencies to each and every phase of the clinical trial.